Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

756 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial.
Beeh KM, Beier J, Meyer M, Buhl R, Zahlten R, Wolff G. Beeh KM, et al. Among authors: beier j. Pulm Pharmacol Ther. 2006;19(4):233-41. doi: 10.1016/j.pupt.2005.07.004. Epub 2005 Sep 1. Pulm Pharmacol Ther. 2006. PMID: 16140027 Clinical Trial.
Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
Beeh KM, Beier J, Candler H, Wittig T. Beeh KM, et al. Among authors: beier j. Int J Chron Obstruct Pulmon Dis. 2016 Nov 23;11:2877-2884. doi: 10.2147/COPD.S117652. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27920515 Free PMC article. Clinical Trial.
The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD.
Singh D, Beier J, Astbury C, Belvisi MG, Da Silva CA, Jauhiainen A, Jimenez E, Lei A, Necander S, Smith JA, Wählby Hamrén U, Xin W, Psallidas I. Singh D, et al. Among authors: beier j. Eur Respir J. 2022 Apr 7;59(4):2100972. doi: 10.1183/13993003.00972-2021. Print 2022 Apr. Eur Respir J. 2022. PMID: 34503985 Free PMC article. Clinical Trial.
Efficacy and safety of AZD7594, an inhaled non-steroidal selective glucocorticoid receptor modulator, in patients with asthma: a phase 2a randomized, double blind, placebo-controlled crossover trial.
Brown MN, Fuhr R, Beier J, Su HL, Chen Y, Forsman H, Hamrén UW, Jackson H, Aggarwal A. Brown MN, et al. Among authors: beier j. Respir Res. 2019 Feb 18;20(1):37. doi: 10.1186/s12931-019-1000-7. Respir Res. 2019. PMID: 30777086 Free PMC article. Clinical Trial.
756 results